IC

Isaac Ciechanover

Chief Business Officer at Cytokinetics

United States

Overview

Work Experience

C

Cytokinetics

  • Chief Business Officer

    2024 - Current

PP

Polaris Partners

  • Partner

    2020 - 2022

KE

KPCB Edge

  • Partner

    2010 - 2012

C

Celgene

  • Executive Director

    2004 - 2010

Pequot Ventures

  • Associate

    2002 - 2003

Education

Investments

EGenesis

Series C

Total Funding: $260M

Relevant Websites